RecruitingNot Applicable

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Indonesia136 participantsStarted 2024-03-18

Plain-language summary

This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Breast cancer patients aged ≥ 18 years with an ECOG score \> 1 * Breast cancer patients with post-axillary lymph node dissection diagnosed with stage 0 and I lymphedema. * Those who have never undergone lymphedema physiotherapy. Exclusion Criteria: * Patients with dermal backflow before axillary lymph node dissection (ALND). * Patients with breast cancer lymphedema who are unable to undergo a 24-month follow-up at Dharmais Cancer Hospital. * Patients with iodine allergy, severe asthma, decreased kidney function, pregnancy, or breastfeeding.

What they're measuring

BCRL improvement rate

Timeframe: 24 months

Trial details

NCT IDNCT07233863

SponsorDharmais National Cancer Center Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2027-03-21

Contact for this trial

Adhitya B Perdana, MEpi

+62 85692445029 adhityabayu@dharmais.co.id

View on ClinicalTrials.gov More Lymphedema Arm trials